Other factors such as LAPTM4B and PLD2 are overexpressed in a variety of cancers and promote cancer proliferation, invasion and metastasis; yet it is not known whether and how they exert cancer progression activities within the exosomal pathway [157]. Here, LAPTM4B is linked to cancer.